147
Participants
Start Date
April 10, 2020
Primary Completion Date
March 31, 2021
Study Completion Date
March 17, 2022
Ixekizumab
Administered SC
Placebo
Administered SC
HuaShan Hospital Affiliated To Fudan University, Shanghai
Peking University First Hospital, Beijing
Beijing Hospital, Beijing
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing
Jiangsu Province Hospital, Nanjing
Anhui Provincial Hospital, Hefei
Afflilated Hospital of Bengbu Medical College, Bengbu
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Pingxiang People's Hospital, Pingxiang
ZhuZhou Central Hospital, Zhuzhou
Wuhan Union Hospital, Wuhan
Wu Han Tongji Hospital, Wuhan
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
1st Hospital affiliated to Medical College of Shantou Univer, Shantou
Shenzhen People's Hospital, Shenzhen
West China Hospital Sichuan University, Chengdu
First Affiliated Hospital of Kunming Medical University, Kunming
People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi
The First Affiliated Hospital of Baotou Medical College, Baotou
Eli Lilly and Company
INDUSTRY